Fixed dose of long-acting erythropoietic stimulating agents at higher frequency improves appetite, reduces inflammation and corrects anaemia in patients on haemodialysis-Reference-Cited by-同舟云学术

Fixed dose of long-acting erythropoietic stimulating agents at higher frequency improves appetite, reduces inflammation and corrects anaemia in patients on haemodialysis

Published:2016-09-01 Issue:10 Volume:43 Page:875-882
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Liu Wen-Sheng¹²³⁴,Chu Da-Chen⁵⁶⁷,Chan Hsiang-Lin⁸,Li Szu-Yuan²⁹,Liu Chih-Kuang¹⁰,Yang Chih-Yu²⁹,Chen Yu-Wei²⁹,Lee Pui-Ching²⁹,Lai Yen-Ting¹¹¹²,Lin Chih-Ching²⁹

Affiliation:

1. Division of Nephrology; Department of Medicine; Taipei City Hospital; Zhong-Xing Branch; Taipei Taiwan

2. School of Medicine; National Yang-Ming University; Taipei Taiwan

3. Institute of Environmental and Occupational Health Sciences; School of Medicine; National Yang-Ming University; Taipei Taiwan

4. College of Science and Engineering; Fu Jen Catholic University; New Taipei City Taiwan

5. Institute of Public Health and Community Medicine Research Centre; National Yang-Ming University; Taipei Taiwan

6. Department of Health Care Management; National Taipei University of Nursing and Health Sciences; Taipei Taiwan

7. Department of Neurosurgery; Taipei City Hospital; Taipei Taiwan

8. Department of Child Psychiatry; Chang Gung Memorial Hospital and University; Taoyuan Taiwan

9. Division of Nephrology, and Department of Medicine; Taipei Veterans General Hospital; Taipei Taiwan

10. College of Medicine & Graduate Institute of Business Administration; Fu Jen Catholic University; New Taipei City Taiwan

11. Department of Physical Medicine and Rehabilitation; National Taiwan University Hospital Hsin-Chu Branch; Hsinchu Taiwan

12. Department of Nursing; Yuanpei University; Hsinchu Taiwan

Funder

Taipei Hospital

Taipei City, Department of Health

intramural grants

Integrated Genome Project

Taipei Veterans General Hospital

National Science Council

Ministry of Science and Technology

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12618/fullpdf

Reference35 articles.

1. Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study;Fliser;Curr Med Res Opin,2010

2. Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease;Macdougall;Clin J Am Soc Nephrol,2006

3. Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study;Francisco;Int J Clin Prac,2006

4. CERA: third-generation erythropoiesis-stimulating agent;Topf;Exp. Opin. Pharmacother,2008

5. Comparative erythropoietin receptor binding kinetics of C.E.R.A. and epoetin-beta determined by surface plasmon resonance and competition binding assay;Jarsch;Pharmacology,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of erythropoietin on SOFA score, Glasgow Coma Scale and mortality in traumatic brain injury patients: a randomized-double-blind controlled trial;Annals of Medicine & Surgery;2024-05-15

2. How renal toxins respond to renal function deterioration and oral toxic adsorbent in pH‐controlled releasing capsule;Environmental Toxicology;2024-04-04

3. The Associations between Erythropoietic Response with Inflammation Markers and Perfluorinated Chemicals in Hemodialysis Patients;Healthcare;2023-02-03

4. Polypharmacy Predicts Onset and Transition of Frailty, Malnutrition, and Adverse Outcomes in Peritoneal Dialysis Patients;The journal of nutrition, health & aging;2022-11-14

5. Intradialytic parenteral nutrition using a standard amino acid solution not for renal failure in maintenance hemodialysis patients with malnutrition: a multicenter pilot study;Renal Replacement Therapy;2022-09-03